<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04351269</url>
  </required_header>
  <id_info>
    <org_study_id>CPR-2212</org_study_id>
    <nct_id>NCT04351269</nct_id>
  </id_info>
  <brief_title>Retrospective Experience Of CIED Implantation</brief_title>
  <official_title>Retrospective Experience of CIED Implantation With Piedmont Athens Regional Electrophysiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aziyo Biologics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aziyo Biologics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to retrospectively gather information on patients who
      underwent a CIED procedure with either a CanGaroo, Tyrx envelope, or no envelope.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single center will retrospectively review up to 600 subjects who underwent implantation of
      a CIED with CanGaroo, Tyrx, or no envelope. All sets of subjects enrolled will also be
      examined for any follow-up visits and/or adverse events that occurred up to 12 months
      post-surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Infection</measure>
    <time_frame>12 months post procedure</time_frame>
    <description>The incidence of major infection post procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pocket Related Issues</measure>
    <time_frame>12 months post procedure</time_frame>
    <description>Any pocket related issues that prompted an office visit</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Cardiac Disease</condition>
  <condition>Heart Failure</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>CanGaroo Envelope</arm_group_label>
    <description>Patients who received a CanGaroo envelope with their CIED implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tyrx Envelope</arm_group_label>
    <description>Patients who received a Tyrx envelope with their CIED implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Envelope</arm_group_label>
    <description>Patients who had their CIED implanted with no envelope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CanGaroo Envelope</intervention_name>
    <description>CanGaroo envelope with CIED implantation</description>
    <arm_group_label>CanGaroo Envelope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tyrx Envelope</intervention_name>
    <description>Tyrx envelope with CIED implantation</description>
    <arm_group_label>Tyrx Envelope</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female patients who underwent a CIED implantation utilizing CanGaroo hydrated in
        saline, CanGaroo hydrated in Antibiotic, Tyrx, or no envelope.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient that had a CIED implanted with either a CanGaroo envelope, a Tyrx
             envelope, or no envelope after July 15, 2015

        Exclusion Criteria:

          -  Any patient that had a CIED implanted with any other type of envelope

          -  Any patient that had a CIED implanted prior to July 15, 2015
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephanie Richardson</last_name>
    <phone>678-492-4712</phone>
    <email>srichardson@aziyo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shawn Piasecki, PhD</last_name>
    <email>spiasecki@aziyo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Piedmont Athens Electrophysiology</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gigi Davis</last_name>
      <email>Gigi.Davis@piedmont.org</email>
    </contact>
    <contact_backup>
      <last_name>Heather Keperling</last_name>
      <email>Heather.Keperling@piedmont.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Woodard, MD, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

